Resumo Este trabalho tem como objetivo avaliar fatores considerados de risco para adquirir leishmaniose cutânea em Salta, área de maior transmissão da Argentina. Aplicou-se um estudo de caso-coorte com observações entre junho de 1989 e dezembro de 1992. Aos casos e aos controles selecionados se realizou: a) um questionário sócio-demográfico; b) descrição das características da vivenda e peridomicílio; c) um exame físico de pele e mucosa nasal e bucal; d) intradermorreação de Montenegro. A análise multivariada mostrou um risco significativo para fatores extradomiciliares (realizar atividades de vaqueira, dormir no lugar de trabalho, ir caçar) e domiciliares (dormir fora do quarto, presença de três ou mais suínos no quintal da casa e existência de janelas sem fechaduras). Esta associação permitiu pela primeira vez em Salta (Argentina), identificar fatores de risco vinculados com a transmissão de leishmaniose na unidade domiciliária. Palavras-chaves: Leishmaniose tegumentar. Fatores de risco.Abstract The objective of this work was evaluate risk factors for acquiring cutaneous leishmaniasis in Salta, the region with the greatest indices of transmission in Argentina. A Case-cohort study was realized from June 1989 to December 1992. The procedures performed on cases and controls included: a) socio-demographic questionnaire; b) domestic and peridomestic environment description; c) physical exam of skin and nasal and oral mucosal; d) Montenegro Skin Test. Multivariate analysis showed a significant risk for factors outside the home (cattle management, hunting, sleeping at the work place) and while at home (sleeping outside of the bedroom, presence of three or more pigs in the yard and windows that cannot be locked in the closed position). This association allowed the identification of risk factors linked to the transmission of leishmaniasis in the home for the first time in Salta (Argentina). Key-words: Tegumentary leishmaniasis. Risk factors.1. Centro Nacional de Diagnóstico e Investigación de Endemo-Epidemias, 2. Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán", Secretaría de Salud, Ministerio de la Salud de Argentina y Acción Social de la Nación, Buenos Aires, Argentina; 3. Ministerio de la Salud de la Provincia, Salta, Argentina.
This work describes the epidemiological pattern of tegumentary leishmaniasis in an area north of Salta, Argentina. The prevalence and incidence were estimated by means of a cross-sectional study and two follow-up studies during two consecutive years. The Montenegro Skin Test (MST) was administered to 7336 subjects at baseline. The prevalence and incidence between 1990 and 1992 of infection (MST reactive) was 38 per mil persons and 4.5 per mil persons/year respectively. The prevalence and incidence of tegumentary leishmaniasis (presence of clinical signs) was 1.8 per mil and 0.8 per mil persons/year, respectively. A physical examination performed on 264 patients with MST reactive during three years revealed that 130 cases (49.2%) had some evident sign of infection (scar and/or lesion), with a clinical presentation compatible with leishmaniasis. Our study demonstrated that after the epidemic outbreak of 1985 the transmission in the study area returned to endemic levels in 1992, and also demonstrated the presence of the asymptomatic infection in the area.
Allogeneic hematopoietic stem cell transplantation and checkpoint blockade therapy are immune-based salvage therapies for Hodgkin's lymphoma; however, the use of programmed death 1 blocking agents in the allogeneic stem cell transplantation setting could augment the incidence of steroid refractory graft-versus-host disease. Few studies suggest that that nivolumab is safe in patients previously treated with an allogeneic stem cell transplantation. Likewise, there are very limited data on the use of nivolumab before allogeneic stem cell transplantation. Here, we report a case of fatal graft-versus-host disease in a patient who underwent allogeneic stem cell transplantation 26 days after the last administration of nivolumab. Careful monitoring and close clinical assessment of atypical presentation for graft-versus-host disease in these patients, interval of time from nivolumab administration to allogeneic stem cell transplantation, drug dosage adjustments or more effective allo prophilaxys should been evaluated in prospective clinical trial.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.